Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Spotlight on liver macrophages for halting injury and progression in nonalcoholic fatty liver disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 15, 2022 Category: Drugs & Pharmacology Authors: Tea Lund Laursen Anders Mellemkj ær Holger Jon M øller Henning Gr ønbæk Konstantin Kazankov Source Type: research
Spotlight on liver macrophages for halting liver disease progression and injury
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 12, 2022 Category: Drugs & Pharmacology Authors: Amit Khurana Umashanker Navik Prince Allawadhi Poonam Yadav Ralf Weiskirchen Source Type: research
Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 20, 2022 Category: Drugs & Pharmacology Authors: Sneh Patel Rhiya Mittal Konstantinos D. Sarantopoulos Anat Galor Source Type: research
Aortic valve stenosis: drivers of disease progression and drug targets for therapeutic opportunities
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 7, 2022 Category: Drugs & Pharmacology Authors: Giuseppe Pinto Gabriele Fragasso Source Type: research
Liver X receptor: a potential target in the treatment of atherosclerosis
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - September 6, 2022 Category: Drugs & Pharmacology Authors: Shreya R. Savla Kedar S Prabhavalkar Lokesh K Bhatt Source Type: research
The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: far beyond the Th1/Th2 imbalance
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - August 30, 2022 Category: Drugs & Pharmacology Authors: Paolo Spagnolo Roberto Tonelli Anna Valeria Samarelli Gioele Castelli Elisabetta Cocconcelli Simone Petrarulo Stefania Cerri Nicol Bernardinello Enrico Clini Marina Saetta Elisabetta Balestro Source Type: research
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - August 19, 2022 Category: Drugs & Pharmacology Authors: Michela Cortesi Michele Zanoni Roberta Maltoni Sara Ravaioli Maria Maddalena Tumedei Francesca Pirini Sara Bravaccini Source Type: research
Neuropathogenesis of HIV and emerging therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 18, 2022 Category: Drugs & Pharmacology Authors: Alina Siddiqui Celestine He Gina Lee Alex Figueroa Alexander Slaughter Jessica Robinson-Papp Source Type: research
Nitric oxide pathway as a plausible therapeutic target in autism spectrum disorders
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 18, 2022 Category: Drugs & Pharmacology Authors: Rishab Mehta Anurag Kuhad Ranjana Bhandari Source Type: research
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - July 7, 2022 Category: Drugs & Pharmacology Authors: Ernestina Marianna De Francesco Francesca Cirillo Veronica Vella Antonino Belfiore Marcello Maggiolini Rosamaria Lappano Source Type: research
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 8, 2022 Category: Drugs & Pharmacology Authors: Alberto Zambelli Riccardo Sgarra Rita De Sanctis Elisa Agostinetto Armando Santoro Guidalberto Manfioletti Source Type: research
IL-36: a therapeutic target for ulcerative colitis?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Yasmina E. Hernandez Santana Naoise Irwin Patrick T. Walsh Source Type: research
Acute myeloid leukemia: therapeutic targeting of stem cells
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Cindy M. Pabon Hussein A. Abbas Marina Konopleva Source Type: research
Dapagliflozin mitigates ovalbumin-prompted airway inflammatory-oxidative successions and associated bronchospasm in a rat model of allergic asthma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Manar Mohammed El Tabaa Aliaa Mohammed Kamel Fattah Mohamed Shaalan Eman Rashad Nageh Ahmed El Mahdy Source Type: research
TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - June 2, 2022 Category: Drugs & Pharmacology Authors: Yara Al Ojaimi Audrey Dangoumau Hugo Alarcan Rudolf Hergesheimer Patrick Vourc ’h Philippe Corcia D ébora Lanznaster H élène Blasco Source Type: research